We are live on ! Find out more
TTOO

T2 Biosystems, Inc
TTOO

Delisted

TTOO was delisted on the 11th of February, 2025.

Back to rankings

51 hedge funds and large institutions have $198M invested in T2 Biosystems, Inc in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 19 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

850% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 2

333% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 3

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

61% more capital invested

Capital invested by funds: $123M → $198M (+$75.4M)

24% more funds holding

Funds holding: 41 → 51 (+10)

Holders
51
Holders Change
+10
Holders Change %
+24.39%
% of All Funds
1.34%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.1%
New
13
Increased
19
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$7.55M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$6.47M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$5.99M
4
TM
Tiger Management
New York
+$4.59M
5
LIM
Lagoda Investment Management
New York
+$4.26M

Top Sellers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
-$7.66M
2
TC
TFS Capital
Pennsylvania
-$378K
3
ARTA
A.R.T. Advisors
New York
-$214K
4
Walleye Trading
Walleye Trading
New York
-$40K
5
TRCT
Tower Research Capital (TRC)
New York
-$22K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$45.7M +$7.55M +140 +20%
AC
2
Aisling Capital
New York
$31M +$3.29M +61 +12%
PVMCV
3
Polaris Venture Management Co V
Massachusetts
$22.1M – – –
Wellington Management Group
4
Wellington Management Group
Massachusetts
$18.3M +$5.99M +111 +50%
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$12M +$6.47M +120 +120%
SM
6
Senvest Management
New York
$10.5M +$3.94M +73 +61%
FVFIGP
7
Flagship Ventures Fund IV General Partner
Massachusetts
$8.12M +$7.98M +148 New
GGHC
8
Gilder Gagnon Howe & Co
New York
$5.19M -$7.66M -142 -60%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$5.15M – – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$4.82M +$486K +9 +11%
TM
11
Tiger Management
New York
$4.63M +$4.59M +85 New
LIM
12
Lagoda Investment Management
New York
$4.33M +$4.26M +79 New
EIM
13
Essex Investment Management
Massachusetts
$3.73M +$863K +16 +31%
BFA
14
BlackRock Fund Advisors
California
$2.96M +$378K +7 +15%
Millennium Management
15
Millennium Management
New York
$2.77M +$755K +14 +38%
SM
16
Sabby Management
Florida
$2.52M +$809K +15 +48%
BIT
17
BlackRock Institutional Trust
California
$2.44M +$1.35M +25 +125%
AP
18
AlpInvest Partners
Netherlands
$1.47M – – –
Northern Trust
19
Northern Trust
Illinois
$1.42M +$162K +3 +13%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$1.07M +$647K +12 +150%
State Street
21
State Street
Massachusetts
$829K +$162K +3 +25%
SIM
22
Spark Investment Management
New York
$801K +$647K +12 +400%
Morgan Stanley
23
Morgan Stanley
New York
$555K +$53.9K +1 +11%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$425K +$108K +2 +33%
WC
25
Woodstock Corp
Massachusetts
$408K – – –
1
2 3

TTOO Hedge Fund Activity: Q4 2015 in Review

51 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q4 2015, worth a combined $198M — up 61% from $123M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new TTOO positions and 3 closed out — a net gain of 10 holders — while 19 added to existing stakes and 2 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $7.55M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $7.66M.

  • 51 institutional investors held T2 Biosystems, Inc (TTOO) as of Q4 2015, up from 41 in Q3 2015.
  • Funds reported $198M of T2 Biosystems, Inc stock for Q4 2015, up 61% quarter-over-quarter.
  • 13 funds opened new T2 Biosystems, Inc positions in Q4 2015 and 3 closed out, a net change of +10 holders.
  • The largest T2 Biosystems, Inc buyer in Q4 2015 was Goldman Sachs, an estimated $7.55M added.
  • The largest T2 Biosystems, Inc seller in Q4 2015 was Gilder Gagnon Howe & Co, an estimated $7.66M sold.

Based on aggregated 13F filings for Q4 2015.